[HTML][HTML] Deep Intronic FGF14 GAA Repeat Expansion in Late-Onset Cerebellar Ataxia

…, R Massie, CH Chalk, AL Lafontaine… - … England Journal of …, 2023 - Mass Medical Soc
Background The late-onset cerebellar ataxias (LOCAs) have largely resisted molecular
diagnosis. Methods We sequenced the genomes of six persons with autosomal dominant LOCA …

[HTML][HTML] Obstructive sleep apnea in neurodegenerative disorders: current evidence in support of benefit from sleep apnea treatment

AC Lajoie, AL Lafontaine, RJ Kimoff… - Journal of clinical …, 2020 - mdpi.com
Obstructive sleep apnea (OSA) is a prevalent disorder characterized by recurrent upper
airway obstruction during sleep resulting in intermittent hypoxemia and sleep fragmentation. …

[HTML][HTML] The interaction between obstructive sleep apnea and Parkinson's disease: possible mechanisms and implications for cognitive function

M Kaminska, AL Lafontaine, RJ Kimoff - Parkinson's disease, 2015 - hindawi.com
Parkinson’s disease (PD) is a relentlessly progressive neurodegenerative disorder associated
with hallmark motor and nonmotor symptoms (NMS) such as sleep disturbances and …

Mild cognitive impairment is linked with faster rate of cortical thinning in patients with Parkinson's disease longitudinally

…, C Bedetti, C Degroot, B Mejia-Constain, AL Lafontaine… - Brain, 2014 - academic.oup.com
Previous studies have shown greater atrophy in grey and white matter of various brain regions
in patients with Parkinson’s disease with mild cognitive impairment than in those without. …

Patterns of cortical thickness and surface area in early Parkinson's disease

T Jubault, JF Gagnon, S Karama, A Ptito, AL Lafontaine… - Neuroimage, 2011 - Elsevier
Idiopathic Parkinson's disease (PD) is a neurodegenerative disorder diagnosed on the basis
of motor symptoms, but that also includes cognitive and visuo-spatial deficits. Though PD is …

Guidance for health care leaders during the recovery stage of the COVID-19 pandemic: a consensus statement

…, S Johnson, A Kooijman, AT Lafontaine… - JAMA network …, 2021 - jamanetwork.com
Importance The COVID-19 pandemic is the greatest global test of health leadership of our
generation. There is an urgent need to provide guidance for leaders at all levels during the …

The spectrum of sleep disorders in Parkinson disease: a review

AC Lajoie, AL Lafontaine, M Kaminska - Chest, 2021 - Elsevier
There is increasing interest in the effects of sleep and sleep disturbances on the brain,
particularly in relation to aging and neurodegenerative processes. Parkinson disease (PD) is the …

[HTML][HTML] Canadian guideline for Parkinson disease

…, O Suchowersky, A Rajput, AL Lafontaine… - Cmaj, 2019 - Can Med Assoc
… Anne-Louise Lafontaine reports receiving personal fees from AbbVie (advisory board), during
the conduct of the study. Janis Miyasaki reports receiving grants from the Patient Centered …

Long‐term efficacy of botulinum toxin A in treatment of various movement disorders over a 10‐year period

…, SK Das, R Ranawaya, AL Lafontaine… - … : official journal of the …, 2002 - Wiley Online Library
Although botulinum toxin A (BTX) has been licensed in Canada for treatment of various
movement disorders since 1990, few clinical studies regarding its long‐term efficacy and side …

Canadian guidelines on Parkinson's disease

…, A Rajput, AL Lafontaine… - The Canadian …, 2012 - pubmed.ncbi.nlm.nih.gov
… 1 , Joyce Gordon, Barbara Snelgrove, Ivy Lim-Carter, Edward Fon, Wayne Martin,
Marguerite Wieler, Oksana Suchowersky, Alex Rajput, Anne L Lafontaine, Jon Stoessl …